Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland

References

• Hedman J, Kaprio J, Poussa T, et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717-22
   PubMed Web of Science ®Google Scholar
• National Agency for Medicines and Finnish Social Insurance Institution: Finnish Statistics on Medicines 2006. Helsinki
   Google Scholar
• Haahtela T, Tuomisto L, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663-70
   PubMed Web of Science ®Google Scholar
• Hallinen T, Karjalainen J, Hahl J, et al. Reduction in total treatment costs through improved pharmaceutical treatment of obstructive airway diseases. Value Health 2007;10:A308
   Web of Science ®Google Scholar
• Haahtela T, Järvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, Revised 2006. www.ginasthma.org
   Google Scholar
• Kankaanranta H, Lahdensuo A, Moilanen E, et al. Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Respir Res 2004;5:17
   PubMed Web of Science ®Google Scholar
• Ikaheimo P, Tuuponen T, Hartikainen S, et al. Achievements and shortcomings of Finnish asthma care. Scand J Public Health 2004;32:310-16
   PubMed Web of Science ®Google Scholar
• Rabe K, Vermeire P, Soriano J, et al. Clinical management of asthma in 1999: the Asthma Insights in Europe (AIRE) study. Eur Respir J 2000;16:802-7
   PubMed Web of Science ®Google Scholar
• Firoozi F, Lemiere C, Beauchesne M-F, et al. Development and validation of database indexes of asthma severity and control. Thorax 2007;62:581-7
   PubMed Web of Science ®Google Scholar
• O’Byrne P, Bisgaard H, Godard P, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-36
   PubMed Web of Science ®Google Scholar
• Barnes, P. Scientific rationale for using a single inhaler for asthma control. Eur Resp J 2007;29:587-95
   PubMed Web of Science ®Google Scholar
• Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004;20:1403-18
   PubMed Web of Science ®Google Scholar
• Rabe K, Pizzichini B, Stallberg S, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006;129:246-56
   PubMed Web of Science ®Google Scholar
• Rabe K, Pizzichini E, Ställberg B, et al. Effect of budesonide in combination with formoterol for reliever medication on asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006;368:744-53
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, D’Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2005;26:819-28
   PubMed Web of Science ®Google Scholar
• Miller E, FitzGerald M. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies – a Canadian economic evaluation. Can J Clin Pharmacol 2008;15:e165-76
   PubMedGoogle Scholar
• Johansson G, Andreasson E, Larsson P, et al. Cost Effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics 2006;24:695-708
   PubMed Web of Science ®Google Scholar
• Price D, Wiren A, Kuna P. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy 2007;62:1189-98
   PubMed Web of Science ®Google Scholar
• Rissanen P, Häkkinen U. Priority-setting in Finnish healthcare. Health Policy 1999;50:143-53
   PubMed Web of Science ®Google Scholar
• Häkkinen U, Lehto J. Reform, change, and continuity in Finnish health care. J Health Polit Pol Law 2005;30:79-96
   PubMed Web of Science ®Google Scholar
• Martikainen J, Kivi I, Linnosmaa I. European prices of newly launched reimbursable pharmaceuticals – a pilot study. Health Policy 2005;74:235-46
   PubMed Web of Science ®Google Scholar
• O'Sullivan A, Thompson D, Drummond M. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value Health 2005;8:67-79
   PubMed Web of Science ®Google Scholar
• Kuna P, Peters M, Manjra A, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007;61:35-6
   Google Scholar
• Hujanen T, Kapiainen S, Tuominen U. Terveydenhuollon yksikkökustannukset Suomessa vuonna 2006. Työpapereita 3. Helsinki: Stakes
   Google Scholar
• VSSHP Price list. The Hospital District of Southwest Finland 2006
   Google Scholar
• TAKSA database of the Association of Finnish Pharmacies for August 2008
   Google Scholar
• Cook J, Drummond M, Glick H, et al. Assessing the appropriateness of combining economic data from multinational clinical trials. Statist Med 2003;22:1955-76
   PubMed Web of Science ®Google Scholar
• Briggs A. Handling uncertainty in economic evaluation and presenting the results. In: Drummond M, McGuire A, eds. Economic Evaluation in Health Care – Merging Theory with Practice. Oxford: Oxford University Press/Office of Health Economics, 2001:172-214
   Google Scholar
• Briggs A, Wonderling D, Mooney C. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40
   PubMed Web of Science ®Google Scholar
• Keränen J, Soini E, Ryynänen O, et al. Economic evaluation comparing From Home To Operation same day admission and preoperative admission 1 day prior to the surgery process: a randomized controlled trial of laparoscopic cholecystectomy. Curr Med Res Opin 2007;23:775-84
   Google Scholar
• Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87
   PubMed Web of Science ®Google Scholar
• Helin-Salmivaara A, Mäkinen R, Haahtela T. Uusien astmapotilaiden lääkehoito vaihtelee alueittain suuresti. Suom Lääkäril 2005;8:920-2
   Google Scholar
• Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95-104
   PubMed Web of Science ®Google Scholar
• O’Brien B. 1996. Economic evaluation of pharmaceuticals: Frankenstein's monster or vampire of trials? Med Care 1996;34:S33-40
   Google Scholar